Efficacy and safety of B-cell receptor signaling pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis of randomized clinical trials - Publication - Bridge of Knowledge

Search

Efficacy and safety of B-cell receptor signaling pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis of randomized clinical trials

Abstract

Citations

  • 8

    CrossRef

  • 0

    Web of Science

  • 1 1

    Scopus

Authors (5)

  • Photo of  Anna Puła

    Anna Puła

  • Photo of dr n. med. Konrad Stawiski

    Konrad Stawiski dr n. med.

  • Photo of  Marcin Braun

    Marcin Braun

  • Photo of  Elżbieta Iskierka-Jażdżewska

    Elżbieta Iskierka-Jażdżewska

  • Photo of  Tadeusz Robak

    Tadeusz Robak

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
LEUKEMIA & LYMPHOMA no. 59, edition 5, pages 1084 - 1094,
ISSN: 1042-8194
ISSN:
1042-8194
Publication year:
2018
DOI:
Digital Object Identifier (open in new tab) 10.1080/10428194.2017.1375101
Verified by:
No verification

seen 63 times

Meta Tags